Case number 2021-2270
Pharmacyclics LLC v. Alvogen, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Dec 22, 2022 | 61 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [892431] [MVH] [Entered: 12/22/2022 11:56 AM] (1) |
| Nov 20, 2022 | 0 | PHARMACYCLICS LLC v. ALVOGEN, INC. [OPINION] [nonprecedential] (0) |
| Nov 15, 2022 | 60 | JUDGMENT. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. Service as of this date by the Clerk of Court. [884094] [MVH] [Entered: 11/15/2022 10:32 AM] (1) |
| Nov 15, 2022 | 59 | OPINION filed for the court by Chen, Circuit Judge; Bryson, Circuit Judge and Hughes, Circuit Judge. Nonprecedential Opinion. Service as of this date by the Clerk of Court. [884091] [MVH] [Entered: 11/15/2022 10:32 AM] (26) |
| Oct 7, 2022 | 58 | Submitted after ORAL ARGUMENT to Panel: Chen, Circuit Judge; Bryson, Circuit Judge and Hughes, Circuit Judge.Arguing counsel: Siegmund Y. Gutman for Natco Pharma Limited and Alvogen, Inc. and Christopher Neil Sipes for Pharmacyclics LLC.Oral Argument Audio available here. [876591] [MJL] [Entered: 10/07/2022 11:26 AM] (0) |
| Oct 3, 2022 | 57 | MODIFIED ENTRY: RESPONSE of Janssen Biotech, Inc. and Pharmacyclics LLC to Doc No. [56]. Service: 10/03/2022 by email. [875469]--[Edited 10/04/2022 by MJL to correct filing event] [Christopher Sipes] [Entered: 10/03/2022 04:35 PM] (2) |
| Sep 30, 2022 | 56 | Citation of Supplemental Authority pursuant to Fed. R. App. P. 28(j) for Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 09/30/2022 by email. [875208] [21-2270] [Siegmund Gutman] [Entered: 09/30/2022 08:33 PM] (2) |
| Sep 6, 2022 | 55 | Form 33A. Certificate of Compliance with Revised Protocols for In-Person Arguments for Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 09/06/2022 by email. [870147] [21-2270] [Siegmund Gutman] [Entered: 09/06/2022 04:47 PM] (2) |
| Sep 6, 2022 | 54 | Response to notice of oral argument from Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 09/06/2022 by email. [870144] [21-2270] [Siegmund Gutman] [Entered: 09/06/2022 04:41 PM] (1) |
| Sep 2, 2022 | 53 | Response to notice of oral argument from Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. Service: 09/02/2022 by email. [869832] [21-2270] [Christopher Sipes] [Entered: 09/02/2022 04:45 PM] (2) |
| Sep 2, 2022 | 52 | Response to notice of oral argument from Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. Service: 09/02/2022 by email. [869829] [21-2270] [Christopher Sipes] [Entered: 09/02/2022 04:41 PM] (1) |
| Aug 22, 2022 | 51 | NOTICE OF ORAL ARGUMENT. Panel: 2210H. Case scheduled October 7, 2022. Response to Notice of Oral Argument due: 09/06/2022. Please review the attached Notice. The response to notice of oral argument form can be found here. The Oral Argument Guide can be found here. Service as of this date by the Clerk of Court. [867692] [MVH] [Entered: 08/22/2022 04:11 PM] (2) |
| Jul 21, 2022 | 50 | Notice from Appellants Alvogen, Inc. and Natco Pharma Limited Notice of Withdrawal of Non-Principal Counsel Amir A. Naini. Service: 07/21/2022 by email. [862280] [21-2270] [Amir Naini] [Entered: 07/21/2022 01:42 PM] (3) |
| Jun 16, 2022 | 49 | Notice from Appellees Janssen Biotech, Inc. and Pharmacyclics LLC regarding conflicts with oral argument. None. Service: 06/16/2022 by email. [856029] [21-2270] [Christopher Sipes] [Entered: 06/16/2022 03:50 PM] (1) |
| May 11, 2022 | 48 | The following conflict dates submitted by Christopher Neil Sipes for Pharmacyclics LLC have been accepted by the court: 09/06/2022, 09/07/2022, 09/08/2022. [849239] [MJL] [Entered: 05/11/2022 02:58 PM] (0) |
| May 11, 2022 | 47 | The following conflict dates submitted by Siegmund Y. Gutman for Natco Pharma Limited and Alvogen, Inc. have been accepted by the court: 08/01/2022, 08/02/2022, 08/03/2022, 08/04/2022, 08/05/2022, 10/04/2022, 10/05/2022, 10/06/2022. [849238] [MJL] [Entered: 05/11/2022 02:56 PM] (0) |
| May 5, 2022 | 46 | Notice from Appellee Janssen Biotech, Inc. regarding conflicts with oral argument. Service: 05/05/2022 by email. [847961] [21-2270] [Christopher Sipes] [Entered: 05/05/2022 04:48 PM] (3) |
| May 5, 2022 | 45 | Notice from Appellee Janssen Biotech, Inc. regarding conflicts with oral argument. Service: 05/05/2022 by email. [847927] [21-2270] [Christopher Sipes] [Entered: 05/05/2022 04:13 PM] (3) |
| May 5, 2022 | 44 | Notice from Appellants Alvogen, Inc. and Natco Pharma Limited regarding conflicts with oral argument. Service: 05/05/2022 by email. [847801] [21-2270] [Siegmund Gutman] [Entered: 05/05/2022 12:42 PM] (2) |
| May 4, 2022 | 42 | 6 paper copies of Doc. No. [38], [32], [25] received from Appellants Alvogen, Inc., Natco Pharma Limited and Appellee Janssen Biotech, Inc.. [847592] [VDW] [Entered: 05/04/2022 04:03 PM] (0) |
| May 2, 2022 | 43 | 6 paper copies of Doc. No. [28] received from Appellees Pharmacyclics LLC and Janssen Biotech, Inc. [847597]--[Edited 05/27/2022 by JCP to include Janssen] [VDW] [Entered: 05/04/2022 04:07 PM] (0) |
| Apr 28, 2022 | 41 | Notice to Advise of Scheduling Conflicts. Arguing counsel must advise of, and show good cause for, any scheduling conflicts during the upcoming court session months listed in the attached notice. The Response to Notice to Advise of Scheduling Conflicts can be found here. The Oral Argument Guide can be found here. [846089] [JCW] [Entered: 04/28/2022 03:42 PM] (1) |
| Apr 28, 2022 | 40 | Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [846088] [JCW] [Entered: 04/28/2022 03:42 PM] (0) |
| Apr 28, 2022 | 39 | ORDER filed granting motion to waive requirements of brief or appendix [36] filed by Appellants. ECF Nos. 37 and 38 are accepted as the nonconfidential and confidential versions, respectively, of the joint appendix. Service as of this date by the Clerk of Court. [846085] [NL] [Entered: 04/28/2022 03:22 PM] (2) |
| Apr 15, 2022 | 38 | MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/15/2022 by email. [843657]--[Edited 04/28/2022 by JCW - compliance review complete] [Siegmund Gutman] [Entered: 04/15/2022 06:31 PM] (0) |
| Apr 15, 2022 | 37 | MODIFIED ENTRY: APPENDIX FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/15/2022 by email. [843656] --[Edited 04/28/2022 by JCW - compliance review complete] [Siegmund Gutman] [Entered: 04/15/2022 06:20 PM] (2323) |
| Apr 15, 2022 | 36 | MOTION of Appellants Alvogen, Inc. and Natco Pharma Limited to waive appendix requirement(s). Service: 04/15/2022 by email. [843646] [21-2270] [Siegmund Gutman] [Entered: 04/15/2022 05:29 PM] (7) |
| Apr 15, 2022 | 35 | Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. Service: 04/15/2022 by email. [843631] [21-2270] [Christopher Sipes] [Entered: 04/15/2022 04:44 PM] (6) |
| Apr 15, 2022 | 34 | Amended Certificate of Interest for Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/15/2022 by email. [843401] [21-2270] [Siegmund Gutman] [Entered: 04/15/2022 10:02 AM] (4) |
| Apr 15, 2022 | 33 | Joint Statement of Compliance with Fed. Cir. R. 33 for Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/15/2022 by email. [843394] [21-2270] [Siegmund Gutman] [Entered: 04/15/2022 09:59 AM] (6) |
| Apr 8, 2022 | 32 | MODIFIED ENTRY: REPLY BRIEF FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 04/08/2022 by email. [842174] --[Edited 04/11/2022 by JCW - compliance review complete] [Siegmund Gutman] [Entered: 04/08/2022 05:13 PM] (42) |
| Mar 11, 2022 | 31 | **TEXT ONLY** ORDER granting motion to extend time to file brief [30] filed by Appellants Natco Pharma Limited and Alvogen, Inc. The reply brief is due 04/08/2022.. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [836476] [JCW] [Entered: 03/11/2022 04:55 PM] (0) |
| Mar 11, 2022 | 30 | MOTION of Appellants Alvogen, Inc. and Natco Pharma Limited to extend time. Service: 03/11/2022 by email. [836423] [21-2270] [Siegmund Gutman] [Entered: 03/11/2022 03:39 PM] (8) |
| Mar 11, 2022 | 29 | Notice from Appellee Pharmacyclics LLC Withdrawal of appearance of Laura Dolbow for Pharmacyclics LLC. Service: 03/11/2022 by email. [836295] [21-2270] [Laura Dolbow] [Entered: 03/11/2022 11:15 AM] (1) |
| Mar 4, 2022 | 28 | MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. Service: 03/04/2022 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [835056] --[Edited 03/07/2022 by JCW - compliance review complete] [Christopher Sipes] [Entered: 03/04/2022 07:30 PM] (84) |
| Dec 30, 2021 | 27 | **TEXT ONLY** ORDER granting motion to extend time to file brief [26] filed by Appellees Janssen Biotech, Inc. and Pharmacyclics LLC. The response brief is due 03/04/2022. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [821967] [EKD] [Entered: 12/30/2021 10:58 AM] (0) |
| Dec 29, 2021 | 26 | MOTION of Appellees Janssen Biotech, Inc. and Pharmacyclics LLC to extend the time to 03/04/2022 to file brief. Service: 12/29/2021 by clerk, email. [821880] [21-2270] [Irena Royzman] [Entered: 12/29/2021 06:08 PM] (13) |
| Dec 7, 2021 | 25 | MODIFIED ENTRY: CORRECTED OPENING BRIEF FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 12/07/2021 by email. [816951] --[Edited 12/08/2021 by JCW - compliance review complete] [Siegmund Gutman] [Entered: 12/07/2021 05:00 PM] (520) |
| Dec 7, 2021 | 24 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Alvogen, Inc. and Natco Pharma Limited, Opening Brief [23], is not in compliance with the rules of this court (see attached). Compliant document due on 12/14/2021. Unless ordered otherwise, the deadline for any responsive filing runs from service of the original version. Service as of this date by the Clerk of Court. [816697] [JCW] [Entered: 12/07/2021 09:48 AM] (2) |
| Dec 6, 2021 | 23 | OPENING BRIEF FILED by Appellants Alvogen, Inc. and Natco Pharma Limited. Service: 12/06/2021 by email. [816611] [21-2270] This document is non-compliant. See Doc No.[24] [Siegmund Gutman] [Entered: 12/06/2021 05:52 PM] (520) |
| Dec 1, 2021 | 22 | ORDER filed denying [19] motion to waive requirements of brief or appendix filed by Natco Pharma Limited and Alvogen, Inc. (Per Curiam). Service as of this date by the Clerk of Court. [815668] [LMS] [Entered: 12/01/2021 03:09 PM] (2) |
| Nov 26, 2021 | 21 | RESPONSE of Appellees Pharmacyclics LLC and Janssen Biotech, Inc. to Doc No. [19]. Service: 11/26/2021 by email. [814890] [21-2270] [Christopher Sipes] [Entered: 11/26/2021 10:38 AM] (14) |
| Nov 24, 2021 | 20 | Amended Certificate of Interest for Appellee Janssen Biotech, Inc.. Service: 11/24/2021 by clerk, email. [814867] [21-2270] [Irena Royzman] [Entered: 11/24/2021 05:59 PM] (3) |
| Nov 23, 2021 | 19 | MOTION of Appellants Alvogen, Inc. and Natco Pharma Limited to waive brief requirement(s). Service: 11/23/2021 by email. [814618] [21-2270] [Siegmund Gutman] [Entered: 11/23/2021 05:54 PM] (8) |
| Nov 3, 2021 | 18 | Amended Entry of appearance for Irena Royzman; Hannah Lee; Christine Wilgoos; Daniel David Williams as counsel for Appellee Janssen Biotech, Inc.. Service: 11/03/2021 by clerk, email. [810043] [21-2270] [Irena Royzman] [Entered: 11/03/2021 03:34 PM] (2) |
| Oct 18, 2021 | 17 | ORDER granting motion to substitute party [15] filed by Appellant Alvogen Pine Brook, LLC. Appellant Alvogen Pine Brook, LLC in 21-2270 substituted by Appellant Alvogen, Inc. in 21-2270. The revised official caption and short caption are reflected in this order; granting motion to extend time to file brief [16] filed by Appellants. The opening brief is due 12/06/2021. Service as of this date by the Clerk of Court. [806486] [LMS] [Entered: 10/18/2021 02:58 PM] (2) |
| Oct 14, 2021 | 16 | MOTION of Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited to extend the time to 12/06/2021 to file brief. Service: 10/14/2021 by email. [805839] [21-2270] [Siegmund Gutman] [Entered: 10/14/2021 05:21 PM] (10) |
| Oct 7, 2021 | 15 | MOTION of Appellant Alvogen Pine Brook, LLC to substitute party. Service: 10/07/2021 by email. [804451] [21-2270] [Siegmund Gutman] [Entered: 10/07/2021 06:44 PM] (10) |
| Sep 17, 2021 | 14 | Corrected Entry of appearance for Irena Royzman; Hannah Lee; Christine Willgoos as counsel for Appellee Janssen Biotech, Inc.. Service: 09/17/2021 by clerk, email. [800309] [21-2270] [Irena Royzman] [Entered: 09/17/2021 01:45 PM] (2) |
| Sep 17, 2021 | 13 | Amended Entry of appearance for Siegmund Y. Gutman; John E. Roberts; Amir A. Naini; David M. Hanna as counsel for Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited. Service: 09/17/2021 by email. [800289] [21-2270] [Siegmund Gutman] [Entered: 09/17/2021 12:59 PM] (2) |
| Sep 15, 2021 | 12 | NOTICE OF NON-COMPLIANCE: The submission of Appellee Janssen Biotech, Inc., Entry of Appearance [5], is not in compliance with the rules of this court (see attached). Service as of this date by the Clerk of Court. [799382] [JCW] [Entered: 09/15/2021 08:39 AM] (1) |
| Sep 15, 2021 | 11 | NOTICE OF NON-COMPLIANCE: The submission of Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited, Entry of Appearance [10], is not in compliance with the rules of this court (see attached). Compliant document due on 09/22/2021. Service as of this date by the Clerk of Court. [799379] [JCW] [Entered: 09/15/2021 08:35 AM] (1) |
| Sep 14, 2021 | 10 | Docketing Statement for the Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited. Service: 09/14/2021 by email. [799333] [21-2270] This document is non-compliant. See Doc No.[11] [Siegmund Gutman] [Entered: 09/14/2021 07:34 PM] (2) |
| Sep 14, 2021 | 9 | Certificate of Interest for Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited. Service: 09/14/2021 by email. [799332] [21-2270] [Siegmund Gutman] [Entered: 09/14/2021 07:33 PM] (4) |
| Sep 14, 2021 | 8 | Entry of appearance for Siegmund Y. Gutman; John E. Roberts; Amir A. Naini; David M. Hanna as counsel for Appellants Alvogen Pine Brook, LLC and Natco Pharma Limited. Service: 09/14/2021 by email. [799331] [21-2270] [Siegmund Gutman] [Entered: 09/14/2021 07:31 PM] (2) |
| Sep 14, 2021 | 7 | Docketing Statement for the Appellee Janssen Biotech, Inc.. Service: 09/14/2021 by clerk, email. [799299] [21-2270] [Irena Royzman] [Entered: 09/14/2021 04:36 PM] (2) |
| Sep 14, 2021 | 6 | Certificate of Interest for Appellee Janssen Biotech, Inc.. Service: 09/14/2021 by clerk, email. [799294] [21-2270] [Irena Royzman] [Entered: 09/14/2021 04:33 PM] (3) |
| Sep 14, 2021 | 5 | Entry of appearance for Irena Royzman; Hannah Lee; Christine Willgoos as counsel for Appellee Janssen Biotech, Inc.. Service: 09/14/2021 by clerk, email. [799292] [21-2270] This document is non-compliant. See Doc No.[12] [Irena Royzman] [Entered: 09/14/2021 04:31 PM] (2) |
| Sep 14, 2021 | 4 | Docketing Statement for the Appellee Pharmacyclics LLC. Service: 09/14/2021 by email. [799187] [21-2270] [Christopher Sipes] [Entered: 09/14/2021 02:48 PM] (2) |
| Sep 14, 2021 | 3 | Certificate of Interest for Appellee Pharmacyclics LLC. Service: 09/14/2021 by email. [799180] [21-2270] [Christopher Sipes] [Entered: 09/14/2021 02:41 PM] (3) |
| Sep 14, 2021 | 2 | Entry of appearance for Christopher N. Sipes; Erica N. Andersen; Brianne Bharkhda; Laura E. Dolbow as counsel for Appellee Pharmacyclics LLC. Service: 09/14/2021 by email. [799178] [21-2270] [Christopher Sipes] [Entered: 09/14/2021 02:38 PM] (2) |
| Aug 31, 2021 | 1 | Appeal docketed. Received: 08/30/2021. [796376]Entry of Appearance is due on 09/14/2021. Certificate of Interest is due on 09/14/2021. Docketing Statement is due on 09/14/2021. Appellants' brief is due on 11/01/2021. [JCW] [Entered: 08/31/2021 03:36 PM] (151) |
